β-Casomorphin-7 as a Potential Inflammatory Marker: How β-Casomorphin-7 Induces Endothelial Dysfunction in...

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Immunology

Background:

• Endothelial dysfunction is a key factor in cardiovascular disease development.
• Beta-casomorphin-7 (BCM-7), derived from A1 beta-casein, is suspected to contribute to endothelial dysfunction.
• Direct effects of BCM-7 on endothelial cells remain largely uninvestigated.

Purpose of the Study:

• To investigate if BCM-7 induces endothelial cell dysfunction.
• To determine if BCM-7 increases inflammatory cytokines and reactive oxygen species (ROS).
• To assess the combined effects of BCM-7 and lipopolysaccharide (LPS) on endothelial cells.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs/TERT2) were treated with BCM-7 (5 µg/mL) and LPS (100 ng/mL).
• Assessed cell viability, apoptosis, necrosis, and intracellular ROS.
• Quantified proinflammatory cytokines and inflammation-regulating enzymes using quantitative real-time PCR.

Main Results:

• BCM-7 significantly increased intracellular ROS production and the expression of IL-6 and IL-8.
• These effects were amplified when BCM-7 was combined with LPS.
• BCM-7 altered the expression of key enzymes: decreased COX-1, increased COX-2, LOX-5, NOS3, and PTGDS.

Conclusions:

• BCM-7 contributes to endothelial dysfunction by enhancing oxidative stress and inflammatory responses.
• The presence of LPS potentiates the detrimental effects of BCM-7 on endothelial cells.
• Findings highlight BCM-7 as a potential factor in cardiovascular disease pathogenesis.